ArticleApplied health economics and health policy2020
Correction to: Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands.
Renée Else Michels et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.